[{"emanumber":4662,"eunumber":1539,"brandname":"Abecma","mah":"Bristol-Myers Squibb Pharma EEIG","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1539.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/abecma","activesubstance":"idecabtagene vicleucel","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210818152502/dec_152502_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210818152502/anx_152502_en.pdf","atccode":"L01","legalscope":"Regulation (EC) No 726/2004","orphan":1.0,"atmp":1.0,"newactivesubstance":1.0,"decision_type":"conditional","prime":null,"legalbasis":null},{"emanumber":5266,"eunumber":1535,"brandname":"Pemazyre","mah":"Incyte Biosciences Distribution B.V.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1535.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/pemazyre","activesubstance":"pemigatinib","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326150925/dec_150925_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326150925/anx_150925_en.pdf","atccode":"L01E","legalscope":"Regulation (EC) No 726/2004","orphan":1.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"conditional","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5204,"eunumber":1538,"brandname":"JEMPERLI","mah":"GlaxoSmithKline (Ireland) Limited","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1538.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/jemperli","activesubstance":"dostarlimab","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210421151305/dec_151305_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210421151305/anx_151305_en.pdf","atccode":"L01X","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"conditional","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5375,"eunumber":1527,"brandname":"Retsevmo","mah":"Eli Lilly Nederland B.V.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1527.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/retsevmo","activesubstance":"selpercatinib","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210211150524/dec_150524_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210211150524/anx_150524_en.pdf","atccode":"L01E","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"conditional","prime":0.0,"legalbasis":null},{"emanumber":5737,"eunumber":1525,"brandname":"COVID-19 Vaccine Janssen","mah":"Janssen-Cilag International NV","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1525.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-janssen","activesubstance":"COVID-19 vaccine (Ad26.COV2-S [recombinant])","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210311151284/dec_151284_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210311151284/anx_151284_en.pdf","atccode":"J07B","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"conditional","prime":0.0,"legalbasis":null},{"emanumber":5127,"eunumber":1537,"brandname":"NEXPOVIO","mah":"Karyopharm Europe GmbH","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1537.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/nexpovio","activesubstance":"selinexor","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326151138/dec_151138_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326151138/anx_151138_en.pdf","atccode":"L01X","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"conditional","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5124,"eunumber":1508,"brandname":"Enhertu","mah":"Daiichi Sankyo Europe GmbH","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1508.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/enhertu","activesubstance":"trastuzumab deruxtecan","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210118150509/dec_150509_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210118150509/anx_150509_en.pdf","atccode":null,"legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"conditional","prime":0.0,"legalbasis":null},{"emanumber":5244,"eunumber":1552,"brandname":"Koselugo","mah":"AstraZeneca AB","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1552.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/koselugo","activesubstance":"selumetinib","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210617151846/dec_151846_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210617151846/anx_151846_en.pdf","atccode":"L01E","legalscope":"Regulation (EC) No 726/2004","orphan":1.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"conditional","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5791,"eunumber":1507,"brandname":"Spikevax","mah":"MODERNA BIOTECH SPAIN, S.L.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1507.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/summaries-opinion/covid-19-vaccine-moderna","activesubstance":"COVID-19 mRNA Vaccine (nucleoside modified)","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210106150575/dec_150575_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210106150575/anx_150575_en.pdf","atccode":"J07B","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"conditional","prime":1.0,"legalbasis":"['article 8.3']"},{"emanumber":5436,"eunumber":1570,"brandname":"Minjuvi","mah":"Incyte Biosciences Distribution B.V.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1570.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/minjuvi","activesubstance":"tafasitamab","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210826152661/dec_152661_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210826152661/anx_152661_en.pdf","atccode":"L01X","legalscope":"Regulation (EC) No 726/2004","orphan":1.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"conditional","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5675,"eunumber":1529,"brandname":"Vaxzevria","mah":"AstraZeneca AB","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1529.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/vaxzevria-previously-covid-19-vaccine-astrazeneca","activesubstance":"COVID-19 Vaccine (ChAdOx1-S [recombinant])","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210129150842/dec_150842_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210129150842/anx_150842_en.pdf","atccode":"J07B","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"conditional","prime":1.0,"legalbasis":"['article 8.3']"},{"emanumber":5031,"eunumber":1504,"brandname":"ELZONRIS","mah":"Stemline Therapeutics B.V.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1504.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/elzonris","activesubstance":"tagraxofusp","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210107150127/dec_150127_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210107150127/anx_150127_en.pdf","atccode":"L01X","legalscope":"Regulation (EC) No 726/2004","orphan":1.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"exceptional","prime":null,"legalbasis":null},{"emanumber":5449,"eunumber":1551,"brandname":"Evkeeza","mah":"Regeneron Ireland Designated Activity Company (DAC)","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1551.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/evkeeza","activesubstance":"evinacumab","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210617151833/dec_151833_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210617151833/anx_151833_en.pdf","atccode":"C10A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"exceptional","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":4691,"eunumber":1566,"brandname":"Bylvay","mah":"Albireo AB","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1566.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/bylvay","activesubstance":"odevixibat","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210716152311/dec_152311_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210716152311/anx_152311_en.pdf","atccode":"A05A","legalscope":"Regulation (EC) No 726/2004","orphan":1.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"exceptional","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5322,"eunumber":1522,"brandname":"Lumoxiti","mah":"AstraZeneca AB","status":"withdrawn","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1522.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/lumoxiti","activesubstance":"moxetumomab pasudotox","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210208150476/dec_150476_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210208150476/anx_150476_en.pdf","atccode":"L01X","legalscope":"Regulation (EC) No 726/2004","orphan":1.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"exceptional","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":1200,"eunumber":null,"brandname":null,"mah":null,"status":null,"ecurl":null,"emaurl":null,"activesubstance":null,"decisionurl":null,"annexurl":null,"atccode":null,"legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"exceptional","prime":0.0,"legalbasis":"['article 10(c)']"},{"emanumber":5434,"eunumber":1536,"brandname":"Thiotepa Riemser","mah":"Esteve Pharmaceuticals GmbH","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1536.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/thiotepa-riemser","activesubstance":"thiotepa","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326150987/dec_150987_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326150987/anx_150987_en.pdf","atccode":"L01A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":null},{"emanumber":5640,"eunumber":1499,"brandname":"Onbevzi","mah":"Samsung Bioepis NL B.V.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1499.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/onbevzi","activesubstance":"bevacizumab","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210111150184/dec_150184_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210111150184/anx_150184_en.pdf","atccode":"L01X","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 10(4)']"},{"emanumber":5011,"eunumber":1518,"brandname":"Rukobia","mah":"ViiV Healthcare BV","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1518.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/rukobia","activesubstance":"fostemsavir","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210204150455/dec_150455_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210204150455/anx_150455_en.pdf","atccode":"J05A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":4965,"eunumber":1506,"brandname":"Kirsty (ex Kixelle)","mah":"Mylan IRE Healthcare Limited","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1506.htm","emaurl":null,"activesubstance":"Insulin aspart","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210205150468/dec_150468_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210205150468/anx_150468_en.pdf","atccode":"A10A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":null,"legalbasis":null},{"emanumber":5327,"eunumber":1515,"brandname":"Abevmy","mah":"Mylan IRE Healthcare Limited","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1515.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/abevmy","activesubstance":"bevacizumab","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210421151264/dec_151264_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210421151264/anx_151264_en.pdf","atccode":"L01X","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 10(4)']"},{"emanumber":5398,"eunumber":1524,"brandname":"Vazkepa","mah":"Amarin Pharmaceuticals Ireland Limited","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1524.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/vazkepa","activesubstance":"icosapent ethyl","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326150935/dec_150935_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326150935/anx_150935_en.pdf","atccode":"C10A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5030,"eunumber":1501,"brandname":"Sogroya","mah":"Novo Nordisk A/S","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1501.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/sogroya","activesubstance":"somapacitan","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210331150964/dec_150964_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210331150964/anx_150964_en.pdf","atccode":"H01A","legalscope":"Regulation (EC) No 726/2004","orphan":1.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":4881,"eunumber":1533,"brandname":"Seffalair Spiromax","mah":"Teva B.V.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1533.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/seffalair-spiromax","activesubstance":"salmeterol / fluticasone propionate","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326150972/dec_150972_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326150972/anx_150972_en.pdf","atccode":"R03A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5591,"eunumber":1534,"brandname":"BroPair Spiromax","mah":"Teva B.V.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1534.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/bropair-spiromax","activesubstance":"salmeterol / fluticasone propionate","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326150971/dec_150971_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326150971/anx_150971_en.pdf","atccode":"R03A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5263,"eunumber":1526,"brandname":"TUKYSA","mah":"Seagen B.V.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1526.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/tukysa","activesubstance":"tucatinib","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210211150461/dec_150461_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210211150461/anx_150461_en.pdf","atccode":"L01E","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5407,"eunumber":1517,"brandname":"Sibnayal","mah":"ADVICENNE","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1517.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/sibnayal","activesubstance":"potassium citrate/potassium hydrogen carbonate","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210430151421/dec_151421_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210430151421/anx_151421_en.pdf","atccode":"A12B","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 10(b)']"},{"emanumber":5107,"eunumber":1502,"brandname":"Roclanda","mah":"Santen Oy","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1502.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/roclanda","activesubstance":"Latanoprost / netarsudil","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210107150135/dec_150135_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210107150135/anx_150135_en.pdf","atccode":"S01E","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 10(b)']"},{"emanumber":5063,"eunumber":1503,"brandname":"Heplisav B","mah":"Dynavax GmbH","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1503.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/heplisav-b","activesubstance":"hepatitis B surface antigen","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210218150463/dec_150463_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210218150463/anx_150463_en.pdf","atccode":"J07B","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5246,"eunumber":1505,"brandname":"Byfavo","mah":"PAION Netherlands B.V.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1505.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/byfavo","activesubstance":"remimazolam","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326150941/dec_150941_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326150941/anx_150941_en.pdf","atccode":"N05C","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5286,"eunumber":1509,"brandname":"Alymsys","mah":"Mabxience Research SL","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1509.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/alymsys","activesubstance":"bevacizumab","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326150929/dec_150929_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326150929/anx_150929_en.pdf","atccode":"L01X","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 10(4)']"},{"emanumber":5556,"eunumber":1510,"brandname":"Oyavas","mah":"STADA Arzneimittel AG","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1510.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/oyavas","activesubstance":"bevacizumab","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326150931/dec_150931_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326150931/anx_150931_en.pdf","atccode":"L01X","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 10(4)']"},{"emanumber":5419,"eunumber":1511,"brandname":"Sunitinib Accord","mah":"Accord Healthcare S.L.U.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1511.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/sunitinib-accord","activesubstance":"sunitinib","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210211150462/dec_150462_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210211150462/anx_150462_en.pdf","atccode":"L01E","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 10(1)']"},{"emanumber":5408,"eunumber":1512,"brandname":"Abiraterone Accord","mah":"Accord Healthcare S.L.U.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1512.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/abiraterone-accord","activesubstance":"abiraterone acetate","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210426151262/dec_151262_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210426151262/anx_151262_en.pdf","atccode":"L02B","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 10(1)']"},{"emanumber":5377,"eunumber":1530,"brandname":"Ontozry","mah":"Angelini Pharma S.p.A","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1530.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/ontozry","activesubstance":"cenobamate","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326150921/dec_150921_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326150921/anx_150921_en.pdf","atccode":"N03A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5729,"eunumber":1521,"brandname":"Lenalidomide Krka d.d.","mah":"KRKA d d., Novo mesto","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1521.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/lenalidomide-krka-dd","activesubstance":"lenalidomide","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210212150510/dec_150510_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210212150510/anx_150510_en.pdf","atccode":"L04A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 10(1)']"},{"emanumber":5391,"eunumber":1523,"brandname":"Ogluo","mah":"Tetris Pharma B.V","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1523.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/ogluo","activesubstance":"glucagon","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210211150519/dec_150519_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210211150519/anx_150519_en.pdf","atccode":"H04A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 10(3)']"},{"emanumber":5188,"eunumber":1513,"brandname":"Yuflyma","mah":"Celltrion Healthcare Hungary Kft.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1513.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/yuflyma","activesubstance":"adalimumab","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210211150470/dec_150470_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210211150470/anx_150470_en.pdf","atccode":"L04A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 10(4)']"},{"emanumber":4974,"eunumber":1500,"brandname":"Xofluza","mah":"Roche Registration GmbH","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1500.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/xofluza","activesubstance":"baloxavir marboxil","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210107150136/dec_150136_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210107150136/anx_150136_en.pdf","atccode":"J05A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5026,"eunumber":1514,"brandname":"Inrebic","mah":"Bristol-Myers Squibb Pharma EEIG","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1514.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/inrebic","activesubstance":"fedratinib","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210208150482/dec_150482_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210208150482/anx_150482_en.pdf","atccode":"L01E","legalscope":"Regulation (EC) No 726/2004","orphan":1.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":null},{"emanumber":5145,"eunumber":1531,"brandname":"Evrysdi","mah":"Roche Registration GmbH","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1531.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/evrysdi","activesubstance":"risdiplam","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326151218/dec_151218_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326151218/anx_151218_en.pdf","atccode":"M09A","legalscope":"Regulation (EC) No 726/2004","orphan":1.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5410,"eunumber":1532,"brandname":"Kesimpta","mah":"Novartis Ireland Limited","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1532.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/kesimpta","activesubstance":"ofatumumab","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326150970/dec_150970_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210326150970/anx_150970_en.pdf","atccode":"L04A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":null},{"emanumber":5319,"eunumber":1561,"brandname":"Verquvo","mah":"Bayer AG","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1561.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/verquvo","activesubstance":"vericiguat","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210716152073/dec_152073_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210716152073/anx_152073_en.pdf","atccode":"C01D","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5348,"eunumber":1519,"brandname":"Lenalidomide Krka","mah":"KRKA, d.d., Novo mesto","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1519.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/lenalidomide-krka-dd-novo-mesto","activesubstance":"lenalidomide","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210211150480/dec_150480_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210211150480/anx_150480_en.pdf","atccode":"L04A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 10(1)']"},{"emanumber":5734,"eunumber":1520,"brandname":"Lenalidomide Krka d.d. Novo mesto","mah":"KRKA d d., Novo mesto","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1520.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/lenalidomide-krka","activesubstance":"lenalidomide","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210211150469/dec_150469_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210211150469/anx_150469_en.pdf","atccode":"L04A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 10(1)']"},{"emanumber":5381,"eunumber":1542,"brandname":"Copiktra","mah":"Secura Bio Limited","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1542.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/copiktra","activesubstance":"duvelisib","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210519151523/dec_151523_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210519151523/anx_151523_en.pdf","atccode":"L01E","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5336,"eunumber":1547,"brandname":"Drovelis","mah":"Gedeon Richter Plc.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1547.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/drovelis","activesubstance":"drospirenone / estetrol","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210519151666/dec_151666_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210519151666/anx_151666_en.pdf","atccode":"G03A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5382,"eunumber":1548,"brandname":"Lydisilka","mah":"Estetra SRL","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1548.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/lydisilka","activesubstance":"drospirenone / estetrol","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210519151527/dec_151527_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210519151527/anx_151527_en.pdf","atccode":"G03A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5117,"eunumber":1546,"brandname":"Ozawade","mah":"Bioprojet Pharma","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1546.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/ozawade","activesubstance":"pitolisant","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210722152147/dec_152147_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210722152147/anx_152147_en.pdf","atccode":"N07X","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5163,"eunumber":1550,"brandname":"Ponvory","mah":"Janssen-Cilag International NV","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1550.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/ponvory","activesubstance":"ponesimod","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210519151522/dec_151522_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210519151522/anx_151522_en.pdf","atccode":"L04A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":4761,"eunumber":1556,"brandname":"Onureg","mah":"Bristol-Myers Squibb Pharma EEIG","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1556.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/onureg","activesubstance":"azacitidine","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210617151848/dec_151848_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210617151848/anx_151848_en.pdf","atccode":"L01B","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5649,"eunumber":1553,"brandname":"Abiraterone Krka","mah":"KRKA d d., Novo mesto","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1553.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/abiraterone-krka","activesubstance":"abiraterone acetate","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210624151894/dec_151894_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210624151894/anx_151894_en.pdf","atccode":"L02B","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 10(1)']"},{"emanumber":5255,"eunumber":1554,"brandname":"Adtralza","mah":"Leo Pharma A/S","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1554.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/adtralza","activesubstance":"tralokinumab","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210617151835/dec_151835_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210617151835/anx_151835_en.pdf","atccode":"D11A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5661,"eunumber":1573,"brandname":"Fingolimod Mylan","mah":"Mylan Ireland Limited","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1573.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/fingolimod-mylan","activesubstance":"fingolimod","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210818152507/dec_152507_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210818152507/anx_152507_en.pdf","atccode":"L04A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":null},{"emanumber":5595,"eunumber":1568,"brandname":"Imatinib Koanaa","mah":"Koanaa Healthcare GmbH","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1568.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/imatinib-koanaa","activesubstance":"imatinib","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210922152752/dec_152752_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210922152752/anx_152752_en.pdf","atccode":"L01E","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 10(3)']"},{"emanumber":5545,"eunumber":1572,"brandname":"Byooviz","mah":"Samsung Bioepis NL B.V.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1572.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/byooviz","activesubstance":"ranibizumab","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210818152501/dec_152501_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210818152501/anx_152501_en.pdf","atccode":"S01L","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":null,"legalbasis":null},{"emanumber":4871,"eunumber":1574,"brandname":"Evrenzo","mah":"Astellas Pharma Europe B.V.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1574.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/evrenzo","activesubstance":"roxadustat","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210818152511/dec_152511_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210818152511/anx_152511_en.pdf","atccode":"B03X","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5475,"eunumber":1577,"brandname":"Voxzogo","mah":"BioMarin International Limited","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1577.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/voxzogo","activesubstance":"vosoritide","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210826152503/dec_152503_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210826152503/anx_152503_en.pdf","atccode":"M05B","legalscope":"Regulation (EC) No 726/2004","orphan":1.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5368,"eunumber":1571,"brandname":"Abiraterone Mylan","mah":"Mylan Ireland Limited","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1571.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/abiraterone-mylan","activesubstance":"abiraterone acetate","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210820152499/dec_152499_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210820152499/anx_152499_en.pdf","atccode":"L02B","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 10(1)']"},{"emanumber":5105,"eunumber":1549,"brandname":"Efmody","mah":"Diurnal Europe B.V.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1549.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/efmody","activesubstance":"hydrocortisone","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210527151530/dec_151530_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210527151530/anx_151530_en.pdf","atccode":"H02A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 10(3)']"},{"emanumber":5089,"eunumber":1564,"brandname":"Imcivree","mah":"Rhythm Pharmaceuticals Netherlands B.V.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1564.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/imcivree","activesubstance":"setmelanotide","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210716152119/dec_152119_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210716152119/anx_152119_en.pdf","atccode":"A08A","legalscope":"Regulation (EC) No 726/2004","orphan":1.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":1.0,"legalbasis":"['article 8.3']"},{"emanumber":5316,"eunumber":1575,"brandname":"Bimzelx","mah":"UCB Pharma S.A.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1575.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/bimzelx","activesubstance":"bimekizumab","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210820152533/dec_152533_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210820152533/anx_152533_en.pdf","atccode":"L04A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5138,"eunumber":1544,"brandname":"Orladeyo","mah":"Biocryst Ireland Limited","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1544.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/orladeyo","activesubstance":"berotralstat","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210430151422/dec_151422_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210430151422/anx_151422_en.pdf","atccode":"B06A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5055,"eunumber":1557,"brandname":"Jayempi","mah":"Nova Laboratories Ireland Limited","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1557.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/jayempi","activesubstance":"azathioprine","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210621151841/dec_151841_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210621151841/anx_151841_en.pdf","atccode":"L04A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 10(3)']"},{"emanumber":5183,"eunumber":1558,"brandname":"Klisyri","mah":"Almirall, S.A.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1558.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/klisyri","activesubstance":"tirbanibulin","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210716152138/dec_152138_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210716152138/anx_152138_en.pdf","atccode":"D06B","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5267,"eunumber":1565,"brandname":"Ryeqo","mah":"Gedeon Richter Plc.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1565.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/ryeqo","activesubstance":"relugolix / estradiol / norethisterone acetate","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210716152087/dec_152087_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210716152087/anx_152087_en.pdf","atccode":"H01C","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":4788,"eunumber":1559,"brandname":"Enspryng","mah":"Roche Registration GmbH","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1559.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/enspryng","activesubstance":"satralizumab","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210624151887/dec_151887_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210624151887/anx_151887_en.pdf","atccode":"L04A","legalscope":"Regulation (EC) No 726/2004","orphan":1.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":5135,"eunumber":1560,"brandname":"Celsunax","mah":"Pinax Pharma GmbH","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1560.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/celsunax","activesubstance":"ioflupane (123I)","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210617151864/dec_151864_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210617151864/anx_151864_en.pdf","atccode":"V09A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 10(1)']"},{"emanumber":5083,"eunumber":1567,"brandname":"Icatibant Accord","mah":"Accord Healthcare S.L.U.","status":"active","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1567.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/icatibant-accord","activesubstance":"icatibant","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210716152116/dec_152116_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210716152116/anx_152116_en.pdf","atccode":"B06A","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 10(1)']"},{"emanumber":5611,"eunumber":1516,"brandname":"Lextemy","mah":"Mylan IRE Healthcare Limited","status":"withdrawn","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1516.htm","emaurl":null,"activesubstance":"bevacizumab","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210421151265/dec_151265_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210421151265/anx_151265_en.pdf","atccode":"L01X","legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":null,"legalbasis":null},{"emanumber":3690,"eunumber":1563,"brandname":"Skysona","mah":"bluebird bio (Netherlands) B.V.","status":"withdrawn","ecurl":"https://ec.europa.eu/health/documents/community-register/html/h1563.htm","emaurl":"https://www.ema.europa.eu/en/medicines/human/EPAR/skysona","activesubstance":"elivaldogene autotemcel","decisionurl":"https://ec.europa.eu/health/documents/community-register/2021/20210716152225/dec_152225_en.pdf","annexurl":"https://ec.europa.eu/health/documents/community-register/2021/20210716152225/anx_152225_en.pdf","atccode":null,"legalscope":"Regulation (EC) No 726/2004","orphan":1.0,"atmp":1.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":823,"eunumber":null,"brandname":null,"mah":null,"status":null,"ecurl":null,"emaurl":null,"activesubstance":null,"decisionurl":null,"annexurl":null,"atccode":null,"legalscope":"Regulation (EC) No 726/2004","orphan":1.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":null},{"emanumber":3785,"eunumber":null,"brandname":null,"mah":null,"status":null,"ecurl":null,"emaurl":null,"activesubstance":null,"decisionurl":null,"annexurl":null,"atccode":null,"legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":1.0,"decision_type":"standard (SmPC confirmed)","prime":0.0,"legalbasis":"['article 8.3']"},{"emanumber":4965,"eunumber":null,"brandname":null,"mah":null,"status":null,"ecurl":null,"emaurl":null,"activesubstance":null,"decisionurl":null,"annexurl":null,"atccode":null,"legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":null,"legalbasis":null},{"emanumber":783,"eunumber":null,"brandname":null,"mah":null,"status":null,"ecurl":null,"emaurl":null,"activesubstance":null,"decisionurl":null,"annexurl":null,"atccode":null,"legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":null,"legalbasis":"['article 10c']"},{"emanumber":2269,"eunumber":null,"brandname":null,"mah":null,"status":null,"ecurl":null,"emaurl":null,"activesubstance":null,"decisionurl":null,"annexurl":null,"atccode":null,"legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":null,"legalbasis":null},{"emanumber":1015,"eunumber":null,"brandname":null,"mah":null,"status":null,"ecurl":null,"emaurl":null,"activesubstance":null,"decisionurl":null,"annexurl":null,"atccode":null,"legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":null,"legalbasis":null},{"emanumber":68,"eunumber":null,"brandname":null,"mah":null,"status":null,"ecurl":null,"emaurl":null,"activesubstance":null,"decisionurl":null,"annexurl":null,"atccode":null,"legalscope":"Council Regulation (EEC) No 2309/93","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":null,"legalbasis":null},{"emanumber":784,"eunumber":null,"brandname":null,"mah":null,"status":null,"ecurl":null,"emaurl":null,"activesubstance":null,"decisionurl":null,"annexurl":null,"atccode":null,"legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":null,"legalbasis":"['article 10c']"},{"emanumber":307,"eunumber":null,"brandname":null,"mah":null,"status":null,"ecurl":null,"emaurl":null,"activesubstance":null,"decisionurl":null,"annexurl":null,"atccode":null,"legalscope":null,"orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":null,"legalbasis":null},{"emanumber":437,"eunumber":null,"brandname":null,"mah":null,"status":null,"ecurl":null,"emaurl":null,"activesubstance":null,"decisionurl":null,"annexurl":null,"atccode":null,"legalscope":"Council Regulation (EEC) No 2309/93","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":null,"legalbasis":null},{"emanumber":270,"eunumber":null,"brandname":null,"mah":null,"status":null,"ecurl":null,"emaurl":null,"activesubstance":null,"decisionurl":null,"annexurl":null,"atccode":null,"legalscope":"Council Regulation (EEC) No 2309/93","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":null,"legalbasis":null},{"emanumber":269,"eunumber":null,"brandname":null,"mah":null,"status":null,"ecurl":null,"emaurl":null,"activesubstance":null,"decisionurl":null,"annexurl":null,"atccode":null,"legalscope":"Council Regulation (EEC) No 2309/93","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":"standard (SmPC confirmed)","prime":null,"legalbasis":null},{"emanumber":4373,"eunumber":null,"brandname":null,"mah":null,"status":null,"ecurl":null,"emaurl":null,"activesubstance":null,"decisionurl":null,"annexurl":null,"atccode":null,"legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":null,"prime":0.0,"legalbasis":"['article 10(4)']"},{"emanumber":2560,"eunumber":null,"brandname":null,"mah":null,"status":null,"ecurl":null,"emaurl":null,"activesubstance":null,"decisionurl":null,"annexurl":null,"atccode":null,"legalscope":"Regulation (EC) No 726/2004","orphan":0.0,"atmp":0.0,"newactivesubstance":0.0,"decision_type":null,"prime":0.0,"legalbasis":"['article 10b']"},{"emanumber":1122,"eunumber":null,"brandname":null,"mah":null,"status":null,"ecurl":null,"emaurl":null,"activesubstance":null,"decisionurl":null,"annexurl":null,"atccode":null,"legalscope":null,"orphan":null,"atmp":null,"newactivesubstance":null,"decision_type":null,"prime":null,"legalbasis":null}]